7th Oncolytic Virotherapy Summit 2022
Evvnt Promotion / evvnt
06.12.2022 - 08.12.2022 Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 8:00 am to 4:00 pm
Temi della conferenza
2021 was a landmark year for clinical readouts within the oncolytic virotherapy field, and now OV developers are poised and ready at the cusp of something remarkable and this promising therapeutic is set to be a critical modality within cancer immunotherapy. With rapid advances in this compelling therapeutic, the Oncolytic Virotherapy Summit returns this December 2022 for its 7th edition.
2021 was a landmark year for clinical readouts within the oncolytic virotherapy field, and now OV developers are poised and ready at the cusp of something remarkable and this promising therapeutic is set to be a critical modality within cancer immunotherapy. With rapid advances in this compelling therapeutic, the Oncolytic Virotherapy Summit returns this December 2022 for its 7th edition.
Scientific organizer
Hanson Wade
Hanson Wade
Annotazioni
Speakers: Antonio Chiocca, Chairman, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Barbara Haertl, Associate Vice President, Manufacturing Operations, Calidi Biotherapeutics
Speakers: Antonio Chiocca, Chairman, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Barbara Haertl, Associate Vice President, Manufacturing Operations, Calidi Biotherapeutics
Informazioni ed Iscrizioni:
https://go.evvnt.com/1259262-2?pid=4832
Ms. Stephanie Nketia
Sanità Pubblica (Public Health), Servizi sanitari
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
